Overview

Treatment Use of Domperidone for Gastroparesis

Status:
Available
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
Domperidone is a drug that may be of benefit to individuals with gastroesophageal reflux disease (GERD), with upper GI symptoms, gastroparesis, and chronic constipation. This is a long-term treatment program for prescription of this drug to all patients who, in the investigators' judgement, could benefit from its use.
Details
Lead Sponsor:
Scott Gabbard, MD
The Cleveland Clinic
Treatments:
Domperidone